News Focus
News Focus
icon url

hlegweakreturns

01/14/14 10:45 AM

#7767 RE: erostratus #7764

Thank you, if 20% success is encouraging to you
Go for it. Yep it was so encouraging they blazed ahead in finishing recruitment. Let's see, when was this written:

"The company disclosed that 25 patients are now enrolled in their melanoma study and will shortly finish enrollment in their 15 patient Merkel Cell Carcinoma (MCC) study study, both of which are Phase II trials."
icon url

erostratus

01/14/14 10:45 AM

#7768 RE: erostratus #7764

Typo fixed*